F-12198

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameF-12198
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionSqualene monooxygenase inhibitors
TargetsSqualene monooxygenase
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Ltd
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A